Coya Therapeutics, Inc. Profile Avatar - Palmy Investing

Coya Therapeutics, Inc.

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enh…

Biotechnology
US, Houston [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of COYA's Analysis
CIK: 1835022 CUSIP: - ISIN: US22407B1089 LEI: - UEI: -
Secondary Listings
COYA has no secondary listings inside our databases.